We are focused on a hard problem: creating new cancer therapies that are more effective and have fewer side effects than traditional treatments.
Our products are targeted radioligands, a technology that hold significant promise to treat cancer. Our company is growing rapidly: we just announced a phase 3 clinical trial for our novel radioligand based prostate cancer treatment, established our U.S. manufacturing center in Indianapolis, and have a pipeline of next generation oncology products in development. We are a creative and agile team accountable to a high standard: to be uniquely better
If you are searching for new and uniquely better career path, you should consider joining the POINT team.

Current Job Openings